Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Mabuchi

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 28, 2002
[New guideline for the management of hyperlipidemia according to patient category and global risk chart]Hiroshi Mabuchi
Journal of Atherosclerosis and Thrombosis|February 10, 2017
Half a Century Tales of Familial Hypercholesterolemia (FH) in JapanHiroshi Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 12, 2002
[Practice guidelines review: Hyperlipidemia]Hiroshi Mabuchi, Tadashi Suehiro
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 31, 2003
Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemiaToshinori Higashikata, Hiroshi Mabuchi
Annals of Clinical Biochemistry|May 22, 2015
Lipoprotein lipase and atherosclerosisJunji Kobayashi, Hiroshi Mabuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[Familial defective apolipoprotein B-100: FDB]Atsushi Nohara, Hiroshi Mabuchi
Nature Reviews. Endocrinology|November 19, 2014
Therapy: PCSK9 inhibitors for treating familial hypercholesterolaemiaHiroshi Mabuchi, Atsushi Nohara
European Journal of Internal Medicine|June 22, 2005
Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor geneJunji Kobayashi, Hiroshi Mabuchi
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemiaAkihiro Inazu, Hiroshi Mabuchi
Journal of Atherosclerosis and Thrombosis|October 22, 2010
An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statinTadashi Ohshiro, Hiroshi Mabuchi, Takao Ohta
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 28, 2002
[New guideline for the management of hyperlipidemia according to patient category and global risk chart]Hiroshi Mabuchi
Journal of Atherosclerosis and Thrombosis|February 10, 2017
Half a Century Tales of Familial Hypercholesterolemia (FH) in JapanHiroshi Mabuchi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 12, 2002
[Practice guidelines review: Hyperlipidemia]Hiroshi Mabuchi, Tadashi Suehiro
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 31, 2003
Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemiaToshinori Higashikata, Hiroshi Mabuchi
Annals of Clinical Biochemistry|May 22, 2015
Lipoprotein lipase and atherosclerosisJunji Kobayashi, Hiroshi Mabuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 8, 2007
[Familial defective apolipoprotein B-100: FDB]Atsushi Nohara, Hiroshi Mabuchi
Nature Reviews. Endocrinology|November 19, 2014
Therapy: PCSK9 inhibitors for treating familial hypercholesterolaemiaHiroshi Mabuchi, Atsushi Nohara
European Journal of Internal Medicine|June 22, 2005
Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor geneJunji Kobayashi, Hiroshi Mabuchi
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemiaAkihiro Inazu, Hiroshi Mabuchi
Journal of Atherosclerosis and Thrombosis|October 22, 2010
An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statinTadashi Ohshiro, Hiroshi Mabuchi, Takao Ohta
Pageof 29